| Financial Year |
March 31 2023 |
| Monetary Funds |
343,318,562.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
84,472,575.20 |
| Advances to Suppliers |
13,088,576.83 |
| Other Receivables |
8,777,137.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
117,654,930.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,936,009.02 |
| Total Current Assets |
576,326,766.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,024,899.40 |
| Investment Properties |
77,078,497.21 |
| Fixed Assetes |
283,913,966.73 |
| Under-construction Projects |
41,958,681.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
209,471,098.43 |
| R&D expenses |
13,400,387.88 |
| Goodwill |
320,354,442.45 |
| Long-Term Deferred and Prepaid Expenses |
1,157,262.92 |
| Deferred Income Tax Assets |
11,206,681.79 |
| Other Non-Current Assets |
2,246,245.05 |
| Sub-Total of Non-Current Assets |
1,068,190,166.14 |
| Total Assets |
1,644,516,932.21 |
| Short-Term Loans |
58,671,839.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,300,000.00 |
| Accounts Payable |
44,684,386.67 |
| Accounts Received In Advance |
1,041,801.40 |
| Employee Compensation Payable |
10,751,103.88 |
| Taxes Payable |
11,451,059.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
153,888,630.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
360,543,537.58 |
| Other Current Liabilities |
1,804,187.54 |
| Sub-Total of Current Liabilities |
666,670,371.42 |
| Long-term Loans |
167,520,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,001,387.72 |
| Other Non-Current Liabilities |
6,696,939.53 |
| Sub-Total of Non-Current Liabilities |
245,185,752.00 |
| Total Liabilities |
911,856,123.42 |
| Paid-In Capital(Or Share Stock) |
241,618,563.00 |
| Capital Surplus |
623,910,687.37 |
| Surplus Reserve |
17,952,791.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-310,717,551.27 |
| Minority Stockholder's Interest |
159,896,318.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
572,764,490.26 |
| Owner's Equity（Stockholder's Equity） |
732,660,808.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,644,516,932.21 |
